Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I understand. The common thread we share is owning this company.
As such we need to be convinced that it is right. Since some things are "up in the air", so to speak they can't be talked about until "set in stone". I don't have all the answers but I have a link I am going to post but not talk about. Draw your own conclusions. http://pressroom.cancer.org/OtisBrawley
OK, Crazy.
Not sure why you think a dental contract is in the works after Sigma Labs has already acquired the technology. ??
Buy, Sell or Hold!
Agreed. After a diagnosis of cancer the patient is left to make her own decisions as to what treatment path to take. A surgeon usually explains the options but then it is up to the patient who is under emotional stress to try to decide which treatment option is best, lumpectomy or mastectomy. Sometimes she makes the wrong decision. In the case of lumpectomy sometimes there is a second surgery to remove more tissue to assure "clean" edges around the place vacated by the tumor. Also the remaining breast tissue is then subject to radiation and the patient undergoes a full regimen of chemo therapy, not necessarily in that order. With a mastectomy there is nothing left to radiate so you skip that but then there is chemo and reconstruction. If there is time to coordinate the schedules of the surgeon and a plastic surgeon both surgeries can be done at the same time. This usually requires implants which in themselves can be dangerous. Perhaps a better option is "Diep Flap" reconstruction which involves the use of the patient's own belly fat to construct new breasts. One in eight women get breast cancer and one in one thousand men get breast cancer so fellas, this isn't just a woman's disease. Until it is eradicated we're not out of the woods yet!
Although it may not eliminate the mammogram, the mrx certainly will be a better tool in the tool box. Most mammogram patients don't enjoy the process but for some, that for health reasons cannot be exposed to iron, the mammogram would still be used.
bizarre!
It as on a TV national news broadcast. I'm not sure of the network. They cited the increasing costs of cancer treatment drugs and decreasing availability. Nothing about increased levels of detection.
Yesterday's Headline: World Health Organization predicts cancer cases to increase 70% over the next 20 years.
Understood. Talk is cheap. It is time to produce! No excuses.
I'm happy for you, rusty......Even though right now the stock is struggling to get to 10 cents, (Mr. Market is tired of hearing about potential and wants to see results in the form of profits before over reacting to the upside.) significant positive developments need to happen this year!
Four years. The first time I bought this stock I was happy to get it for a buck ten. How long ago was that? Though this stock requires patience, you're right. The time is now! Mr. Maslow is 76. Dr. Flynn is 79. They currently have the funding they need. All the staffing is in place. CRS is moving forward. MDA is under contract. At least three companies are interested in the metals. Marketing has begun. The key is transforming the company from revenues in exchange for shares to ongoing revenues from operations.
One thing on Dr. Flynn's "wish list" is the equipment to manufacture nano particles in house which totals about $2 million. I'm thinking this is of premium importance with the MDA
work to begin soon.
Right. According to the 8k, purchase price was $.055 and the warrants (strike price $.085) were thrown in with the shares.
All this for a measly $100,000. 1,818,182 shares. The value to the company is the addition of this investor to the shareholder list adds credibility when trying to raise more money. The inference being, "if its good enough for him its probably good for me."
So does he!
All our docks could be rotten by then!
Sure hope my ship comes in before my dock rots!...It would be nice to have a couple deals made before the patents expire!
I don't recall that presentation. Though copper is a better conductor than aluminum, price is a consideration. Current testing of the nano structured aluminum involves resistivity. The nano aluminum is less resistive than aluminum at certain levels of plastic deformation. For exact numbers contact Dr. Lowe.
Mg, Al
I'm not at liberty to say as sensitive negotiations are still "in progress". I will, however say that representatives of the companies are very excited about the "potential" of the new metals. Anything more would be pure speculation...but this is a speculative stock.
St. Paul. Why?
Bigger!
Set your sights higher than BGC.
You're right AL is bigger than Mg. The contract process is on hold until Mr. Tsoupanarious is back to work.
Yes. The application will be medical.
I'll drink to that! It could have been even better had MDA allowed its people to be quoted in this release but they are reserving "anonymity" until the process is validated. Meanwhile, the market says, "Show me the money".
I agree that selling pressure drove the mhtx price down long term but buying pressure can bring prices down in the short term. This is a strategy used by high speed computer traders to get into stocks at lowball prices by flooding the market with low bids only to stop and let the prices recover so they can get out with a profit a few days later. I'm not saying that the "Algos" are trading mhtx. they aren't. I'm just saying that bids and bid sizes are worthy of attention.
It wouldn't be worth the paperwork for Big Theo to trade $800 worth of stock and I don't trade because I might have material information that may not already be public.....The music is getting louder
Big Theo stated that the decision was made prior to Mr. Tsoupanarious's surgery. You contend that your conversation with ssc that began on or about January 17th influenced that decision.
The surgery was January 8th. I'm sorry, hunch. What this adds up to is, the management doesn't even look at message boards let alone be influenced by them.
I'm hearing music again...
By the way, The strike price on the warrants is $.055 as that has been the base line price for all fund raising and other deals since the Chip Mason deal. $.055 was the market price the day the Mason deal was signed and so it didn't seem fair to other potential "whales" to not get the same rate. That's how they came up with it. I don't think I would have done it that way. I would have wanted the warrant strike to be $.15 or better. That way there would have been at least some performance incentive to get the stock price over $.15. The way it is now, the market has already exceeded the warrant strike price so in theory, they could be exercised and sold upon receipt for a profit since the market price is higher than $.055. In reality this is not a good move because it immediately would create 14 million new shares which by dilution should cause some selling interest. Then they would immediately be for sale and with the low volume we're running this would cause some further declining stock prices. It is going to take some really great news to bump the buying pressure up enough to cause the market to be able to absorb that kind of selling volume plus the normal selling volume that could take place after a news driven spike.(long awaited profit taking)
A song comes to mind; I can't decide if it is "Don't Stop thinkin' about tomorrow" or "Monday Monday"!
We'll have to wait and see.
I'm going to sit back, relax and enjoy the ride!
The point was, "buying interest" is larger than "selling interest" which doesn't really equate to selling pressure. Its normal for buyers to want a better price so in order for sellers to make the transaction they come down to the buyer's price. So we have buying pressure but not at higher prices because the news or lack of news, as it is, just isn't a very compelling reason to support a higher price...
I just checked. The bid size was 167k. The ask size was 10k.
They don't take advice from message boards!!!
All of Dr. Flynn's early testing was done with human breast cancers in animals. I'm a bit wary of MD Anderson UT Houston. First, they do cancer research. Good! Second they make their money by treating cancer. Bad! The research side is all excited about the "new" technology. The treatment side is out to squash it! If they get their way they will say, "Our researchers tested it and we found it to be irrelevant." Why? Because the cancer treatment industry is fat and happy with the status quo and resistant to new technologies that could interrupt their cash flow. Follow the money trail to the answers to why this has taken so long. I'm a big fan of this technology ever since my wife's breast cancer experience and subsequent barbaric treatments. You get to know the industry when you live it in person and I'm telling you it is a financial juggernaut. It will be fantastic if MDA has good things to say about the technology because it could be that their intention is to kill it.
I'm with you there. I would like to see more information released about minor accomplishments that typically get passed over as not significant enough to warrant a press release. There are only so many people in the company and they spend so much time doing what they do that they forget to keep the market and the shareholders informed. This lack of information gets viewed as deceptiveness. Press releases are expensive to small cash strapped companies but I think a regular blog on the company's website to keep investors abreast of what is happening would be inexpensive and beneficial.
The company has a lot of proving to do to start and maintain a rising stock price. First, it has to prove that it can transition from revenues in exchange for shares to revenues from operations. In order for that to happen it has to prove that it can convert it's technologies to ongoing revenues. The fact that they paid themselves and diluted the shares in the process is behind us now and is no different than all of the fund raising the company has done to date. That's how we got 463 million shares outstanding. That process has to stop and be replaced by revenues from operations.